Genotoxicity and carcinogenicity studies of soy isoflavones

International Journal of Toxicology

Volumn 21, Issue 4, 2002, Pages 277-285

  Misra, R R ^a   Hursting, S D ^a   Perkins, S N ^a   Sathyamoorthy, N ^a   Mirsalis, J C ^b   Riccio, E S ^b   Crowell, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

Carcinogenicity; Chemoprevention; Genistein; Genotoxicity; Soy Isoflavones

Indexed keywords

DAIDZEIN; DNA TOPOISOMERASE; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; PROTEIN P53; PTI G 2535; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGENICITY; CHEMOPROPHYLAXIS; COLONY FORMATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOSE RESPONSE; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPHOMA CELL; MALE; METABOLIC ACTIVATION; MOUSE; MUTAGENESIS; NONHUMAN; RISK BENEFIT ANALYSIS; SALMONELLA TYPHIMURIUM; SOYBEAN; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; BONE MARROW CELLS; CARCINOGENICITY TESTS; CARCINOGENS; ESCHERICHIA COLI; FEMALE; GENISTEIN; LYMPHOMA; MALE; MICE; MICE, KNOCKOUT; MICRONUCLEUS TESTS; MUTAGENS; MUTATION; NEOPLASMS, EXPERIMENTAL; SALMONELLA TYPHIMURIUM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; GLYCINE MAX; RODENTIA; SALMONELLA TYPHIMURIUM;

EID: 0036360471     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/10915810290096441     Document Type: Article

References (45)

1. Plasma concentrations of phytoestrogens in Japanese men
2. Genistein, a specific inhibitor of tyrosine-specific protein kinases
3. Comparative effects of neonatal exposure of male rats to potent and weak environmental estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: Evidence for stimulatory effects of low estrogen levels
4. Genistein: Does it prevent or promote breast cancer?
5. Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat
6. Selection of cancer chemopreventive agents based on inhibition of topoisomerase II activity
7. p53-independent induction of p21 (WAF1/CIP1) reduction of cyclin B1 and G2/M arrest bly the isoflavone genistein in human prostate carcinoma cells
8. Validation and characterization of the L5178Y TK+/- mouse lymphoma mutagen assay system
9. Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/neu receptors in the rat dorsolateral prostate
10. Dietary genistein: Perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat
11. Infant cancer in the U.S.: Histology-specific incidence and trends, 1973 to 1992
12. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
13. Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring
14. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis
15. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo
16. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice
17. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis
18. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in Hep G2 cell cultures
19. Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes
20. A simple fluorescent staining procedure for micronuclei and RNA-contaning erythrocytes using Hoechst 33258 and pyronin Y
21. Inhibition of 17-beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells
22. In vitro bioassays of non-steroidal phytoestrogens
23. Revised methods for the Salmonella mutagenicity test
24. Detection of carcinogens as mutagens: Bacterial tester strains with R-factor plasmids
25. Soy intake and cancer risk: A review of the in vitro and in vivo data
26. Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP
27. p53, mutations, and apoptosis in genistein-exposed human lymphoblastoid cells
28. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats
29. Effect of genistein on topoisomerase activity and on the growth of [val 12] Ha-Rastransformed NIH 3T3 cells
30. Estimates of the world-wide incidence of twenty-five major cancers in 1990
31. Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16α-fluoro-5-androsten-17-one
32. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet
33. Role of 17-beta-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol synthesis
34. Topoisomerase II inhibitor-related acute myeloid leukemia
35. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group
36. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic pituitary axis in rats
37. Stimulation of pS2 expression by diet-derived compounds
38. Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones
39. Cancer chemoprevention agent development strategies for genistein
40. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
41. Inhibition of tumor promoter-induced hydrogen peroxide formaion in vitro and in vivo by genistein
42. Influence of perinatal genistein exposure on the development of MNU-induced mammary carcinoma in female Sprague-Dawley rats
43. Chromosome painting analysis of spontaneous and methyl methanesulfonate-induced trifluorothymidine-resistant L5178Y cell colonies
44. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice
45. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis and angiogenesis